{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:22:39Z","timestamp":1768537359278,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":6738,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1111\/j.1538-7836.2004.00732.x","type":"journal-article","created":{"date-parts":[[2004,11,15]],"date-time":"2004-11-15T12:07:50Z","timestamp":1100520470000},"page":"1135-1142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers"],"prefix":"10.1016","volume":"2","author":[{"given":"L.A.","family":"O'Brien","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hegadorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Benford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Racz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rapson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lillicrap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb43698.x","article-title":"Von willebrand factor and platelet function","volume":"614","author":"Weiss","year":"1991","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.1982.tb03888.x","article-title":"Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease","volume":"52","author":"Tuddenham","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0020","doi-asserted-by":"crossref","first-page":"8099","DOI":"10.1021\/bi00399a013","article-title":"Identification of disulfide\u2010bridged substructures within human von Willebrand factor","volume":"26","author":"Marti","year":"1987","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1083\/jcb.113.1.195","article-title":"Assembly and routing of von Willebrand factor variants: the requirements for disulfide\u2010linked dimerization reside within the carboxy\u2010terminal 151 amino acids","volume":"113","author":"Voorberg","year":"1991","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0030","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V55.6.1056.1056","article-title":"Factor VIII\u2010related protein circulates in normal human plasma as high molecular weight multimers","volume":"55","author":"Hoyer","year":"1980","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0025-6196(12)61204-X","article-title":"Structure and function of von Willebrand factor: relationship to von Willebrand's disease","volume":"66","author":"Ruggeri","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.1989.tb00226.x","article-title":"Binding of von Willebrand factor to glycoproteins Ib and IIb\/IIIa complex: affinity is related to multimeric size","volume":"73","author":"Federici","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0045","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1073\/pnas.87.16.6306","article-title":"Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor","volume":"87","author":"Dent","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0050","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood.V83.6.1551.1551","article-title":"Characterization of leu777pro and ile865thr type IIA von Willebrand disease mutations","volume":"83","author":"Lyons","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0055","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations","volume":"267","author":"Lyons","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0060","unstructured":"National Committee for Clinical Laboratory (NCCLS) Standards. Collection, transport and preparation of blood specimens for coagulation testing and performance of coagulation assays. Document H21\u2013A2. 1991; 11."},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0065","first-page":"215","article-title":"A one\u2010stage factor VIII assay and its use on venous and capillary plasma","volume":"7","author":"Hardisty","year":"1962","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0070","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0038-1645215","article-title":"Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes","volume":"63","author":"Buddle","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0075","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","article-title":"A rapid non\u2010enzymatic method for the preparation of HMW DNA from blood for RFLP studies","volume":"19","author":"Lahiri","year":"1991","journal-title":"Nucl Acids Res"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-1119(89)90358-2","article-title":"Site\u2010directed mutagenesis by overlap extension using the polymerase chain reaction","volume":"77","author":"Ho","year":"1989","journal-title":"Gene"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0042-6822(73)90341-3","article-title":"A new technique for the assay of infectivity of human adenovirus 5 DNA","volume":"52","author":"Graham","year":"1973","journal-title":"Virology"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0090","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0095","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1182\/blood.V98.6.1842","article-title":"Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders","volume":"98","author":"Moore","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/jcph.1999.6201","article-title":"Namd2: Greater scalability for parallel molecular dynamics","volume":"151","author":"Kale","year":"1999","journal-title":"J Computational Physics"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0105","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease. For the Subcommittee on Von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0110","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1172\/JCI113425","article-title":"Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene","volume":"81","author":"Verweij","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-2002-27820","article-title":"Laboratory diagnosis of congenital von Willebrand disease","volume":"28","author":"Budde","year":"2002","journal-title":"Semin Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0120","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.V83.8.2171.2171","article-title":"Shear stress enhances the proteolysis of von Willebrand factor in normal plasma","volume":"83","author":"Tsai","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0125","first-page":"512","article-title":"A new mutation, ala1500\u2192glu, responsible for type 2a von Willebrand disease","volume":"72","author":"Wang","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-0038-1650564","article-title":"A novel mutation gly 1672\u2192arg in type 2a and a homozygous mutation in type 2b von Willebrand disease","volume":"76","author":"Hagiwara","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0135","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1055\/s-0038-1648511","article-title":"Characterization of three mutations causing von Willebrand disease type IIA in five unrelated families","volume":"67","author":"Inbal","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0140","doi-asserted-by":"crossref","first-page":"23209","DOI":"10.1016\/S0021-9258(18)50078-8","article-title":"Characterization of recombinant von Willebrand factor corresponding to mutations in type IIA and type IIB von Willebrand disease","volume":"267","author":"Ribba","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00001721-199208000-00008","article-title":"Molecular study of von Willebrand disease: identification of potential mutations in patients with type IIA and type IIB","volume":"3","author":"Pietu","year":"1992","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0150","first-page":"757","article-title":"Analysis of the relationship of von Willebrand disease (VWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA VWD mutation (iie865 to thr)","volume":"48","author":"Iannuzzi","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0155","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-0038-1657568","article-title":"Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. INSERM network on molecular abnormalities in von Willebrand disease","volume":"78","author":"Meyer","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0160","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1055\/s-0037-1614609","article-title":"Recombinant VWF type 2a mutants r834q and r834w show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease","volume":"81","author":"Lankhof","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00732.x_bb0165","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood.V91.6.2032","article-title":"Molecular modeling of ligand and mutation sites of the type a domains of human von Willebrand factor and their relevance to von Willebrand's disease","volume":"91","author":"Jenkins","year":"1998","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2004.00732.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622179973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622179973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2004.00732.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:31:09Z","timestamp":1761532269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622179973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S1538783622179973"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00732.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00732.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}